Treatment with alemtuzumab in a case of refractory primary cutaneous CD30-negative CD8-positive cytotoxic large T-cell lymphoma [2]

1. Gutierrez, A.
2. Rodriguez, J.
3. Ramos, R.
4. Gines, J.
5. Sampol, A.
6. Galmes, B.
7. Besalduch, J.